Usana health sciences, inc. (USNA)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities
Net earnings

26,552

30,754

24,222

21,378

24,172

32,331

31,040

33,907

28,946

-5,851

23,769

23,259

21,358

21,882

30,098

25,762

22,299

23,967

25,609

25,416

19,680

21,300

19,498

19,301

16,537

20,282

16,753

24,210

17,779

18,447

17,490

16,745

13,751

13,161

12,385

13,856

11,350

Adjustments to reconcile net earnings to net cash provided by (used in) operating activities
Depreciation and amortization

3,494

3,556

3,533

3,788

3,866

4,109

4,049

4,154

4,531

4,313

4,131

4,200

3,466

3,552

3,176

3,234

3,520

2,694

2,654

2,293

2,337

2,125

2,277

2,197

2,211

2,174

2,239

2,328

2,303

2,218

2,198

2,214

2,196

2,113

2,115

2,110

2,136

Right-of-use asset amortization

2,255

2,169

2,118

1,954

2,023

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Gain) loss on sale of property and equipment

-

-47

-11

-3

-23

-1

-27

5

-1,782

-10

-14

-4

10

-61

-15

-1

-39

-2

27

-3

-25

-15

-15

-12

-4

-7

17

3

3

-70

-2

86

22

-

-

-

-

Equity-based compensation expense

3,394

2,857

4,083

4,769

3,832

3,929

3,968

3,253

3,805

3,771

3,709

3,804

4,198

2,579

4,542

4,812

4,609

4,129

2,564

2,178

2,210

3,876

1,858

2,235

1,836

1,511

1,686

2,058

2,369

2,026

2,566

2,752

2,866

2,810

2,937

1,567

3,235

Excess tax benefits from equity-based payment arrangements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,285

4,003

4,826

910

10,838

609

1,531

1,856

-104

5,836

1,549

185

664

2,399

204

176

0

0

13

35

Deferred income taxes

4,611

6,999

88

-13,770

3,048

4,223

1,769

-8,395

3,102

32,107

-10,758

-3,423

1,380

-1,451

-366

49

-1,932

-579

-964

-452

-577

-190

-244

-459

-146

-382

353

1,662

-819

1,856

6,928

-3,944

-729

-126

508

-238

-1,743

Changes in operating assets and liabilities:
Inventories

-5,153

-9,129

-9,887

2,396

3,630

1,163

8,495

8,974

4,469

-1,498

-6,159

-1,662

3,265

-6,888

3,133

4,397

392

4,639

8,978

3,701

5,753

3,854

-1,922

-2,989

-45

1,784

3,876

-399

6,522

3,092

-996

-1,281

-2,185

545

2,103

1,201

-640

Prepaid expenses and other assets

4,262

882

-4,737

-1,854

-1,480

-770

-3,052

2,069

3,379

1,333

-1,572

-1,015

-3,756

-2,430

532

12,680

-1,033

1,482

-5,157

6,612

-890

3,265

-4,620

1,805

3,339

-688

5,858

9,431

-6,136

-2,882

7,891

1,746

-414

2,039

-1,954

1,612

-5,721

Income tax payable related to tax benefit from equity award activity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,437

3,851

4,826

910

10,786

539

1,531

1,856

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-174

3,083

-2,627

-371

1,750

-4,575

2,309

-103

649

2,493

1,737

-1,450

263

-1,938

517

2,161

-2,081

613

703

376

789

1,912

-164

619

-3,704

1,742

893

-942

1,097

78

502

-1,251

-314

-1,112

700

474

1,440

Other liabilities

-10,237

-1,972

4,262

-2,051

-31,043

801

16,781

16,565

-15,449

15,391

-17,296

24,632

-29,245

21,148

-554

15,564

-13,624

12,092

1,784

3,105

3,960

15,923

6,433

3,692

-10,975

2,883

10,960

8,259

-1,850

3,554

-815

5,542

2,472

2,377

3,536

-1,096

-5,199

Total adjustments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,558

8,892

-

9,682

0

6,195

Net cash provided by (used in) operating activities

30,786

55,740

50,314

15,158

5,521

40,426

54,500

37,675

19,518

55,133

13,037

53,703

1,901

55,151

33,763

34,506

13,471

36,949

28,350

22,606

23,561

37,790

36,145

28,781

2,469

34,300

17,297

26,991

20,305

29,182

19,677

21,303

22,643

16,640

22,067

13,856

17,545

Cash flows from investing activities
Additions to notes receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

3

0

1

3

1

1

31

1,547

1,336

639

1,091

1,429

1,579

1,131

1,090

1,142

-

-

-

-

-

-

-

-

Receipts on notes receivable

85

86

53

37

55

48

41

4,459

301

37

0

152

107

206

162

394

49

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments for net investment hedge

1,089

0

0

0

1,660

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of investment securities held-to-maturity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

2,383

1,488

-

-

-

-

-

-

-

-

-

-

-

-

Maturities of investment securities held-to-maturity

-

0

2,999

23,855

36,685

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

3,374

3,436

5,701

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of property and equipment

-

6

5

0

6

0

0

346

35

6

5

1

10

-

-

-

-

-

-

-

-

0

2

2

6

0

32

12

3

6

0

97

51

-

-

-

-

Purchases of property and equipment

7,266

5,197

4,242

4,553

2,577

2,571

2,226

3,688

2,948

4,052

2,199

3,588

3,381

6,651

12,384

4,692

8,971

7,261

6,690

3,936

5,842

7,155

3,163

9,124

979

1,745

3,345

2,089

872

1,621

3,364

1,220

2,227

2,085

2,764

5,118

676

Net cash provided by (used in) investing activities

-8,270

-5,105

-1,185

21,275

32,509

15,611

-41,425

-40,577

-2,612

-4,009

-2,194

-3,435

-3,264

-6,440

-12,220

-4,298

-8,925

-7,259

-6,509

-3,967

-7,389

-8,491

-426

-9,160

1,811

-11,967

-4,444

-3,167

-2,011

-1,615

-3,364

-1,123

-2,176

-2,052

-2,764

-5,117

-676

Cash flows from financing activities
Excess tax benefits from equity-based payment arrangements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,285

4,003

4,826

910

10,838

609

1,531

1,856

-104

5,836

1,549

185

664

2,399

204

176

0

0

13

35

Repurchase of common stock

57,029

0

92,377

27,623

30,000

79,785

22,647

0

2,943

-

-

-

-

0

0

0

64,610

-

-

-

-

-

-

-

-

0

0

0

18,085

-

-

-

-

758

7,362

16,817

8,522

Borrowings on line of credit

-

0

0

0

5,000

-

-

-

-

-

-

-

-

0

1,200

1,500

71,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on line of credit

-

0

0

0

5,000

-

-

-

-

-

-

-

-

1,200

0

67,500

5,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments related to tax withholding for net-share settled equity awards

1,823

305

34

235

1,413

433

16

52

308

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments for debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

250

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) financing activities

-58,852

-305

-92,476

-27,858

-31,413

-80,218

-22,663

855

-3,251

-

-

-

-

-1,200

1,200

-66,000

1,140

-58,896

4,003

4,826

910

-4,349

-65,944

-44,578

1,856

-104

5,836

2,003

-17,900

-33,372

-5,619

-25,727

176

-758

-7,362

-16,765

-8,487

Effect of exchange rate changes on cash, cash equivalents and restricted cash

-4,436

1,802

-5,362

-2,331

4,170

-1,356

-7,097

-8,206

5,519

4,546

1,717

2,807

1,957

-6,625

-598

-2,311

1,605

-1,779

-2,578

-1,105

361

-1,562

-304

491

-746

-235

604

-818

-186

43

369

-79

168

206

-568

252

114

Net increase (decrease) in cash, cash equivalents and restricted cash

-40,772

52,132

-48,709

6,244

10,787

-25,537

-16,685

-10,253

19,174

55,479

-37,565

53,075

594

40,886

22,145

-38,103

7,291

-30,985

23,266

22,360

17,443

23,388

-30,529

-24,466

5,390

21,994

19,293

25,009

208

-5,762

11,063

-5,626

20,811

14,036

11,373

-7,774

8,496

Cash paid during the period for:
Interest

2

1

3

2

5

1

1

2

2

7

3

4

2

6

0

170

147

-

-

-

-

125

5

0

6

-

-

-

-

-

-

-

-

0

1

2

7

Income taxes

9,694

9,248

10,517

24,986

10,163

11,439

12,712

27,037

19,495

5,474

19,603

10,842

10,087

11,465

12,971

19,556

8,587

16,864

3,940

11,982

2,996

15,239

1,753

9,176

787

1,398

4,514

19,939

1,101

2,123

11,715

12,552

741

5,258

5,798

13,139

344

Cash received during the period for:
Income tax refund

-

110

263

74

5,095

247

385

2,017

49

0

0

0

4,700

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash investing and financing activities:
Right-of-use assets obtained in exchange for lease obligations

1,914

7,386

2,946

2,640

20,286

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Credits on notes receivable

-

-

-

-

-

-

-

-

-

-326

221

0

191

146

290

347

505

500

410

1

55

120

484

54

62

-

-

-

-

-

-

-

-

-

-

-

-

Accrued purchases of property and equipment

608

775

-436

408

251

145

-101

-8

159

-

-

-

-

453

-570

-322

2,655

4,957

1,757

-761

910

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-